Global kidney disease

dc.creatorHerrera Añazco, Percy
dc.creatorMezones-Holguín, Edward
dc.creatorHernández, Adrian V.
dc.date.accessioned2014-07-04T00:36:54Z
dc.date.available2014-07-04T00:36:54Z
dc.date.created2014-07-04T00:36:54Z
dc.date.issued2014-07-03
dc.identifier0140-6736
dc.identifier10.1016/S0140-6736(13)62087-5
dc.identifierhttp://hdl.handle.net/10757/322401
dc.identifier1474-547X
dc.identifierThe Lancet
dc.description.abstractWe read with interest the Lancet Series on Global Kidney Disease. Valerie Luyckx and colleagues describe the economics and medical management of chronic kidney disease in sub-Saharan Africa.1 We note clear similarities with patients in Peru. Indeed, in Peru, the Ministry of Health (MINSA)—which covers 70% of the population—does not have a comprehensive programme for the management of patients with chronic kidney disease, including renal replacement therapies. However, the Social Security System (Essalud)—which covers 20% of the population—has a chronic kidney disease programme.
dc.languageeng
dc.publisherElsevier B.V.
dc.relationhttp://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2813%2962087-5/fulltext
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourceUniversidad Peruana de Ciencias Aplicadas (UPC)
dc.sourceRepositorio Académico - UPC
dc.subjectkidney disease
dc.subjectstatistics
dc.titleGlobal kidney disease
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución